The Beauty Health CompanySKINNASDAQ
LOADING
|||

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating
Hold
13 analysts·Moderate coverage
23%
Rating Distribution
Strong Buy
00%
Buy
323%
Hold
754%
Sell
323%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 70% higher.

Bear Case
$1.60
+7%
Consensus
$2.55
+70%
Bull Case
$3.50
+133%
Price Range13 analysts
Low
Consensus
High
$1.60
$3.50
Current Target
Current Price
$1.50
Upside to Target
$1.05

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 14, 2026Jefferies
Beauty Health assumed with a Hold at Jefferies
Target:$1.60
+4.6%from $1.53
Sep 19, 2025Roth Capital
Beauty Health initiated with a Buy at Roth Capital
Target:$3.50
+47.7%from $2.37
May 5, 2025Canaccord Genuity
Beauty Health price target lowered to $1.25 from $1.50 at Canaccord
Target:$1.25
+17.9%from $1.06
Mar 13, 2025Canaccord Genuity
Beauty Health price target lowered to $1.50 from $1.75 at Canaccord
Target:$1.50
+11.9%from $1.34
Aug 9, 2024Piper Sandler
The Beauty Health Company (SKIN) PT Lowered to $1 at Piper Sandler
Target:$1.00
-12.3%from $1.14
May 10, 2024Piper Sandler
The Beauty Health Company (SKIN) PT Lowered to $2.50 at Piper Sandler
Target:$2.50
-23.3%from $3.26
Mar 13, 2024Piper Sandler
The Beauty Health Company (SKIN) PT Raised to $3 at Piper Sandler
Target:$3.00
-29.4%from $4.25
Mar 13, 2024Stifel Nicolaus
The Beauty Health Company (SKIN) PT Raised to $4 at Stifel
Target:$4.00
-5.9%from $4.25
Apr 28, 2022Piper Sandler
Piper Sandler Maintains Overweight on Beauty Health, Lowers Price Target to $26
Target:$26.00
+97.9%from $13.14